Hu, Na
Xiao, Fengjiao
Chen, Yechao
Gu, Qiaoling
Liang, Pei
Xu, Yin
Liu, Jinchun
Liu, Yunxing
Li, Yi-chen
Xu, Yinqiu
Liu, Mengyin
Chen, Dayu https://orcid.org/0000-0002-6947-1869
Zhang, Haixia
Funding for this research was provided by:
Jiangsu Pharmaceutical Association Aosaikang Hospital Pharmacy Funding (A202212)
Article History
Received: 24 March 2025
Accepted: 30 April 2025
First Online: 17 May 2025
Declarations
:
: Na Hu, Fengjiao Xiao, Yechao Chen, Qiaoling Gu, Pei Liang, Yin Xu, Jinchun Liu, Yunxing Liu, Yi-chen Li, Yinqiu Xu, Mengyin Liu, Dayu Chen, and Haixia Zhang have nothing to disclose. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
: The study was performed in accordance with the ethical standards of the Declaration of Helsinki of 1964 and its later amendments. Informed consent was waived due to the observational nature of the study and no interventions were made. This study has obtained ethical approval from the Ethics Committee of the Drum Tower Hospital of Nanjing Medical University (Nanjing Drum Tower Hospital Project number: 2022-191-01) and was registered in the Chinese Clinical Trial Registry (website: , identifier: ChiCTR2300067946). Given the nature of this observational study, no intervention was made to standard care.